|
TXLNG expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.422750E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.03950000002384E-06 |
| Normal-vs-Stage2 |
8.110800E-01 |
| Normal-vs-Stage3 |
6.493400E-01 |
| Normal-vs-Stage4 |
3.311800E-01 |
| Stage1-vs-Stage2 |
2.204000E-01 |
| Stage1-vs-Stage3 |
6.124100E-02 |
| Stage1-vs-Stage4 |
4.003600E-01 |
| Stage2-vs-Stage3 |
9.639800E-01 |
| Stage2-vs-Stage4 |
6.760200E-01 |
| Stage3-vs-Stage4 |
5.997800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.92899999999341E-05 |
| Normal-vs-AfricanAmerican |
4.825900E-02 |
| Normal-vs-Asian |
1.252970E-01 |
| Caucasian-vs-AfricanAmerican |
4.954400E-01 |
| Caucasian-vs-Asian |
8.214000E-01 |
| AfricanAmerican-vs-Asian |
9.596000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.20649995444455E-09 |
| Normal-vs-Female |
7.602100E-02 |
| Male-vs-Female |
1.14570000153691E-08 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.188160E-01 |
| Normal-vs-Extreme_Weight |
1.42289999782719E-08 |
| Normal-vs-Obese |
2.594200E-01 |
| Normal-vs-Extreme_Obese |
1.812970E-04 |
| Normal_Weight-vs-Extreme_Weight |
2.036300E-02 |
| Normal_Weight-vs-Obese |
7.088600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.314400E-02 |
| Extreme_Weight-vs-Obese |
4.277900E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.911200E-01 |
| Obese-vs-Extreme_Obese |
3.099700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.692000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.265700E-02 |
| Normal-vs-Age(61-80Yrs) |
4.6299000000527E-07 |
| Normal-vs-Age(81-100Yrs) |
1.75483000000032E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.127640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.959700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.148040E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.447950E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.496900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.409400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.45589999950491E-08 |
| Normal-VS-Type2 PRCC |
4.609700E-02 |
| Normal-VS-KIRP CIMP |
1.522440E-01 |
| Normal-VS-Unclassified PRCC |
4.058200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.237900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.589680E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.088400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.377800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.319600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.535600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.226400E-04 |
| Normal-vs-N1 |
7.093800E-01 |
| Normal-vs-N2 |
9.307400E-01 |
| N0-vs-N1 |
1.350050E-02 |
| N0-vs-N2 |
2.171800E-01 |
| N1-vs-N2 |
9.514800E-01 |
|
|
